Clovis Oncology, Inc. (CLVS): Check out this CLVS mention in the lates...

Home > Boards > US Listed > Biotechs > Clovis Oncology, Inc. (CLVS)

Followed By	0
Posts	50
Boards Moderated	0
Alias Born	02/16/2021

Wednesday, June 02, 2021 4:35:00 PM

Re: None

Check out this CLVS mention in the latest report from DRP Gazett:

3 Short Squeeze Candidates for Interested Traders | June 2, 2021

"Clovis Oncology Inc (NASDAQ: CLVS) is a biotechnology company. Currently, 42% of the float is short. The short interest could be prime for a squeeze as the company is set to present four abstracts featuring data from clinical studies evaluating Rubraca and/or lucitanib and one abstract on real world data of PARP inhibitor usage, during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting to be held virtually, June 4-8, 2021. Which is why now is a good time to look at this biotech company."

Recent CLVS News

Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 06/28/2022 12:31:43 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 06/16/2022 08:36:45 PM
Clovis Oncology Highlights Phase 1 Data from Ongoing Clinical Studies of Targeted Radiotherapy Candidate FAP-2286 at SNMMI Annual Meeting • Business Wire • 06/14/2022 06:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 06/09/2022 08:48:47 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 06/09/2022 08:46:44 PM
Clovis Oncology (CLVS) Gets a Hold Rating from H.C. Wainwright • TipRanks • 06/06/2022 03:55:10 PM
Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Significantly Improves Progression-Free Survival in Women with Advanced Ovarian Cancer in Primary Efficacy Analyses Regardless of BRCA Mutation and HRD Status • Business Wire • 06/06/2022 12:00:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/03/2022 08:17:04 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/03/2022 08:16:50 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/03/2022 08:16:35 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/03/2022 08:16:16 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/03/2022 08:16:15 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 06/01/2022 08:16:51 PM
Quarterly Report (10-q) • Edgar (US Regulatory) • 05/05/2022 08:43:52 PM
Clovis Oncology to Present at the BofA Securities 2022 Healthcare Conference • Business Wire • 05/05/2022 12:00:00 PM
Clovis Oncology (CLVS) Receives a Buy from H.C. Wainwright • TipRanks • 05/05/2022 10:17:04 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 05/04/2022 12:25:39 PM
Clovis Oncology Announces First Quarter 2022 Operating Results and Provides Update on Clinical Development Programs • Business Wire • 05/04/2022 12:00:00 PM
Clovis Oncology Highlights Rubraca® (Rucaparib) and FAP-2286 Data to be Presented at 2022 ASCO Annual Meeting • Business Wire • 04/28/2022 12:00:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 04/27/2022 08:11:06 PM
Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 04/27/2022 08:06:49 PM
Clovis Oncology to Announce First Quarter 2022 Financial Results and Host Webcast Conference Call on May 4 • Business Wire • 04/20/2022 12:00:00 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 04/11/2022 05:59:39 PM
Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022 • Business Wire • 04/08/2022 12:00:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 04/05/2022 08:17:51 PM

More CLVS News

InvestorsHub NewsWire

Pacific Booker Minerals Inc. Announces Annuals Posted and Project Update • PBMLF • Jul 1, 2022 9:30 AM

Maison Luxe Reports Best Ever Annual Revenues of Approximately $ 17.6 mil. for 2022 as Compared to Approximately $ 5.2 mil. for 2021, an Increase of Over 300% and Poised for Rapid Expansion in 2023 • MASN • Jun 30, 2022 9:58 AM

Global Fiber Technologies Secures Second Round of Inventory Financing • GFTX • Jun 30, 2022 9:41 AM

Sugarmade Announces Fully Executed LOI Toward Minority Stake Acquisition of Turnkey Cannabis Cultivation Property • SGMD • Jun 30, 2022 8:30 AM

HPIL(HPIL) Updates Shareholders • HPIL • Jun 30, 2022 8:30 AM

Emerging Markets Report: Cheaper. Simpler. More efficient. Ready to scale. • SPYR • Jun 29, 2022 11:41 AM

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System • ONPH • Jun 29, 2022 9:23 AM

Infobird Co., Ltd Provides Digital and Intelligent Customer Engagement Solution to Enhance Patient Vaccination Notification Services for a Top-10 Global Pharmaceutical Company's Subsidiary • IFBD • Jun 29, 2022 8:34 AM

Goldshore Resources Drills 78.35m at 1.17 g/t Au and delineates higher grade lenses within Moss lake Deposit • GSHRF • Jun 29, 2022 8:33 AM

PSYC Provides Encouraging Update on its Investment in The Conscious Fund • PSYC • Jun 29, 2022 8:30 AM

Health Advance Inc. (OTC: HADV): Embrace their CBD Innovation Before Everyone Else Does! • HADV • Jun 29, 2022 8:00 AM

Resgreen Group Announces LilBuddy ™ Pilot Testing of Payload Capacity Exceeding Original Expectations • RGGI • Jun 29, 2022 6:00 AM

IGEN's CEO provides mid-year progress update for 2022 • IGEN • Jun 29, 2022 6:00 AM

Splash Beverage Group to Distribute TapouT through Save-A-Lot Grocery Stores in 32 States. • SBEV • Jun 28, 2022 8:23 AM

RYU Apparel Inc. (TSXV: RYU) (OTCQB: RYPPF) Announces Company Achievements and Roadmap For Shareholders with growth in Operations, Rollup Acquisition Strategy, and Disruptive Technology Opportunities • RYPPF • Jun 27, 2022 11:48 AM

Start posting your company's news
Only $200 per official company press release!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
2M
3M
6M
1Y
2Y
3Y
5Y

Detailed Quote

Follow Board

Keyboard Shortcuts

Report TOS Violation